ABSTRACT

Presents new chapters discussing the latest research on low-molecular-weight heparins, as well as agents such as pentasaccharide, TFP1, soluble thrombomodulin, and alfimeprase.

Completely revised and expanded throughout, New Therapeutic Agents in Thrombosis and Thrombolysis details strategies to

  • target conventional and recently charac
  • chapter 1|7 pages

    Overview of Hemostasis and Fibrinolysis

    chapter 4|14 pages

    Overview of New Anticoagulant Drugs

    chapter 7|13 pages

    Antithrombotic Therapy and Cancer

    chapter 12|15 pages

    Clinical Use of Argatroban

    chapter 13|16 pages

    Hirudin for Acute Coronary Syndromes

    chapter 14|24 pages

    Clinical Development of Bivalirudin

    chapter 16|7 pages

    Oral-Direct Thrombin Inhibitors

    chapter 17|7 pages

    Orally Active Heparin

    chapter 20|18 pages

    Soluble Thrombomodulin

    chapter 21|7 pages

    Overview: Antiplatelet Therapy

    chapter 22|21 pages

    Abciximab

    chapter 27|19 pages

    Thienopyridines: Ticlopidine and Clopidogrel

    chapter 29|2 pages

    Overview of New Therapeutic Agents

    chapter 32|11 pages

    Lanoteplase

    chapter 39|24 pages

    Alfimeprase

    chapter 41|25 pages

    Thrombolysis and Ultrasound